SavedAdd your journal

Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2002 / Cilt: 7 - Sayı: 1

Total antioxidant capasity in patients with chronic viral hepatitis

Kronik viral hepatitli hastalarda total antioksidan kapasite

Özlem KANDEMİR
Gülçin ESKANDARİ
Gülden ERSÖZ
PİR ALİ KAYA
Pages
49–52
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The findings of this study and those of some related studies, which are limited in number, suggest that antioxidant treatment may contribute to current treatments.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Total antioxidant capacity (TAOC) was investigated in 38 chronic hepatitis patients (25 hepatitis B, 13 hepatitis C).
📊
Key Findings & Data:Control group included 22 healthy persons.
💡
Conclusion & Impact:The findings of this study and those of some related studies, which are limited in number, suggest that antioxidant treatment may contribute to current treatments.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hepatit C · kronik · Hepatit B

Abstract

Total antioxidant capacity (TAOC) was investigated in 38 chronic hepatitis patients (25 hepatitis B, 13 hepatitis C). Control group included 22 healthy persons. Results of the colqrimetric measurements of TA-OC with Randox kit showed that TAOC was significantly lower in patients with chronic hepatitis compared to the controls (p= 0.0013). The findings of this study and those of some related studies, which are limited in number, suggest that antioxidant treatment may contribute to current treatments.

Özet

Kronik hepatitli 38 hastada (25 kronik hepatit B, 13 kronik hepatit C) total antioksidan kapasite araştırıldı. Kontrol grubu 22 sağlıklı bireyden oluşturuldu. Total antioksidan kapasite ölçümü kolorimetrik yöntemle (Randoks kiti kullanılarak) yapıldı. Antioksidan kapasitenin hasta grubunda kontrol grubuna göre düşük oldu-ğu görüldü (p- 0.0013). Bu konuda yapılan kısıtlı sayıdaki çalışmalar ve bizim bulgularımız kronik hepatit B ve C infeksiyonu olan olgularda antioksidan tedavinin mevcut tedavilere katkıda bulunabileceğini düşündürmek-tedir.

🔖

Cite This Article

KANDEMİR, Ö., ESKANDARİ, G., ERSÖZ, G., KAYA, P. A. (2002). Total antioxidant capasity in patients with chronic viral hepatitis. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 7 - Sayı: 1, 49–52. https://ajindex.com/articles/224463

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60
  2. Koziel MJ. The role of immunresponses in the pathogenesis of hepatitis C virus infection. J Viral Hepat 1997;4(Suppl 2):31-41
  3. Kageyama F, Kobayashi Y, Kawasaki T, Toyokuni S, Uchida K, Nakamura H. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 2000,95:1041-50
  4. Tamer L, Polat G, Eskandari G, Ercan B, Atik U. Serbest radikaller. Mersin Üniversitesi Tıp Fakültesi Dergisi 2000;l:52-8
  5. Yıldırmak T. infeksiyon hastalıklarında oksidatif stres ve antioksidan tedavi. Flora Dergisi 1998;3:224-34
  6. Yıldırmak T, Demirag F. Akut ve kronik viral hepatitlerde total antioksidan kapasite ve lipid peroksit düzeyleri. Viral Hepatit Dergisi 1998;4:51-3. 7. de Maria N, Colantoni A, Fagiuoli S, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996;21:291-5
  7. Desmet WJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1518-20
  8. Fabris C, Pirisi M, Panoozzo MP, et al. Intensity of inflamatory damage and serum lipid peroxide concentrations in liver disease. J Clin Pathol 1993;46:364-7
  9. Schwarz KB. Oxidative stress during viral infection: A review. Free Radic Biol Med 1996;21:641-9
  10. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaer R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mi- tochondrial radical generation. J Biol Chem 1992;267:5317-23
  11. Paradis V, Mathurin P, Kollinger M, et al. In situ detection of lipid peroxidation in chronic hepatitis C: Correlation with pathological features. J Clin Pathol 1997;50:401-6
  12. Poli G, Parola M, Leonarduzzi G, Pinzani M. Modulation of hepatic fibrogenesis by antioxidants. Molec Aspect Med 1993; 14:259-64
  13. Paradis V, Kollinger M, Fabre M, Holstege A, Poynard T, Bedossa P. In situ detection of lipid peroxidation by products in chronic liver diseases. Hepatology 1997;26:135-42
  14. Look MP, Gerard A, Rao GS, et al. Interferon/antioxidant combination therapy for chronic hepatitis C: A controlled pilot study. Antiviral Res 1999;43:113-22
  15. Ideo G, Bellobuono A, Tempini S, Mondazzi L. Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not respon